foxo4-dri user experiences The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4-DRI 10mg | PeptideX Research
FOXO4 DRI 10mg PeptideX Research FOXO4 DRI FOXO4 p53 Interaction Blocker MedChemExpress Development of a novel senolytic by precise disruption of FOXO4 p53 complex eBioMedicine FOXO4 DRI 10MG Raw Amino
Pay in 4 interest-free payments of $5.99 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11



